Skip to content
10-Q

Quarterly Report

GlobeStar Therapeutics Corp

0001161697-24-000130

← back to feed
Filed
Mar 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Mar 11, 2024 1.16B sh
Operating Cash Flow Q1 2024 · Dec 31, 2023 −$42.8K
Operating Cash Flow Q1 2024 · Dec 31, 2022 −$39.14K
Stockholders Equity Q1 2024 · Dec 31, 2023 −$1.53M
Stockholders Equity Q1 2024 · Sep 30, 2023 −$1.43M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$1.24M
Stockholders Equity Q1 2024 · Sep 30, 2022 −$1.19M
Current Liabilities Q1 2024 · Dec 31, 2023 $1.53M
Current Liabilities Q1 2024 · Sep 30, 2023 $1.43M
Total Liabilities Q1 2024 · Dec 31, 2023 $1.53M
Total Liabilities Q1 2024 · Sep 30, 2023 $1.43M
Net Income Q1 2024 · Dec 31, 2023 −$163.76K
Net Income Q1 2024 · Dec 31, 2022 −$165.91K
Operating Income Q1 2024 · Dec 31, 2023 −$155.87K
Operating Income Q1 2024 · Dec 31, 2022 −$155.24K
Stock Issued Q1 2024 · Feb 28, 2022 6M sh